COSMECCA KOREA, a global cosmetics OGM specialist, reported strong growth in both revenue and operating profit for the first quarter of 2026, supported by the rapid expansion of its Korean subsidiary and stable performance of its U.S. subsidiary.
On a consolidated basis, the company recorded revenue of KRW 185.1 billion (approx. JPY 20.36 billion), operating profit of KRW 21.9 billion (approx. JPY 2.41 billion), and net profit of KRW 19.6 billion (approx. JPY 2.16 billion) for the January-March 2026 period. These figures represent year-on-year increases of 56.4%, 78.0%, and 112.8%, respectively.
The results were driven by a diversified customer portfolio, improved product mix, and enhanced production efficiency. The Korean subsidiary's rapid growth and the stable performance of U.S. subsidiary Inglewood Lab were key contributors to the consolidated results.
Revenue from the Korean subsidiary reached KRW 142.2 billion (approx. JPY 15.64 billion) in Q1, up 91.3% year-on-year, fueled by diversified orders from K-beauty indie brands and expanded global exports. By product category, skincare sales surged 106.5% and suncare sales grew 173.6% compared to the same period last year.
Inglewood Lab, the U.S. subsidiary, posted consolidated Q1 revenue of KRW 49.7 billion (approx. JPY 5.47 billion), a 16.9% increase year-on-year. Skincare product sales rose 25.3%, supporting steady growth. Demand from K-beauty brands for dual production in Korea and the U.S. in response to tariff issues, along with production transfers from existing brands, also contributed to the revenue increase.
In China, COSMECCA CHINA recorded Q1 revenue of KRW 6.4 billion (approx. JPY 700 million), down 27.1% year-on-year, due to delays in the supply of key raw materials and changes in some secondary material suppliers, which deferred certain sales.
COSMECCA KOREA plans to strengthen its supply chain capabilities in China while continuing to diversify its customer base, focusing on color cosmetics, and proposing strategic product categories. In the second half of the year, the company aims to expand collaboration with global clients to meet the overseas growth demand of K-beauty brands.
In March 2026, COSMECCA KOREA increased its stake in Inglewood Lab from 50.0% to 66.7% through a tender offer, enhancing control over its U.S. operations and strengthening the execution of its Korea-U.S. dual production strategy.
A COSMECCA KOREA official stated, "Supported by balanced growth between our Korean and U.S. subsidiaries, both revenue and profitability have improved. We will further solidify our mid- to long-term growth foundation through customer portfolio diversification, technological competitiveness enhancement, and the advancement of our global production strategy."
Source: Read the original report | Published: May 15, 2026